Narcissin

Narcissin

SCHEMBL7167500

COc1cc(-c2oc3cc(O)cc(O)c3c(=O)c2O[C@@H]2O[C@H](CO[C@@H]3O[C@@H](C)[C@H](O)[C@@H](O)[C@H]3O)[C@@H](O)[C@H](O)[C@H]2O)ccc1O

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ P4HB P07237 3/20 1.00
▸ SYNJ2 O15056 1/20 1.00
▸ KDM4E B2RXH2 5/20 0.85
▸ MAPT P10636 3/20 0.85
▸ HES1 Q14469 2/20 0.85
▸ FANCF Q9NPI8 2/20 0.85
▸ POLB P06746 2/20 0.85
▸ GAA P10253 2/20 0.85
▸ XDH P47989 2/20 0.85
▸ EPHX2 P34913 2/20 0.85
▸ KDM1A O60341 1/20 0.85
▸ PRSS1 P07477 1/20 0.85
▸ PRSS2 P07478 1/20 0.85
▸ ADRA2A P08913 1/20 0.85
▸ HMGB1 P09429 1/20 0.85
▸ CFTR P13569 1/20 0.85
▸ ADRA2C P18825 1/20 0.85
▸ MAOA P21397 1/20 0.85
▸ ACHE P22303 1/20 0.85
▸ MAPK1 P28482 1/20 0.85

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Narcissin SCHEMBL31236364 1.00 P4HB (1.00) P4HBSYNJ2KDM4EMAPTHES1
Narcissin SCHEMBL1305421 1.00 P4HB (1.00) P4HBSYNJ2KDM4EMAPTHES1
Narcissin SCHEMBL30389758 1.00 P4HB (1.00) P4HBSYNJ2KDM4EMAPTHES1
Narcissin SCHEMBL1305418 1.00 P4HB (1.00) P4HBSYNJ2KDM4EMAPTHES1
Narcissin SCHEMBL15773535 1.00 P4HB (1.00) P4HBSYNJ2KDM4EMAPTHES1
Narcissin SCHEMBL29516911 1.00 P4HB (1.00) P4HBSYNJ2KDM4EMAPTHES1
Narcissin SCHEMBL31236367 1.00 P4HB (1.00) P4HBSYNJ2KDM4EMAPTHES1
Rutin SCHEMBL6427268 0.95 P4HB (0.90) P4HBSYNJ2KDM4EMAPTHES1
SCHEMBL30305712 0.95 P4HB (0.90) P4HBSYNJ2KDM4EMAPTHES1
SCHEMBL25292788 0.94 P4HB (0.89) P4HBSYNJ2KDM4EMAPTHES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 26 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114652836-A T3SS small-molecule inhibitor and screening method and application thereof 山东大学 2022-06-24 — — CN claimed
US-20250339399-A1 SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM BEIJING CREATRON INSTITUTE OF PHARMACEUTICAL RES CO LTD (CN) 2025-11-06 — — US disclosed
US-20250250647-A1 STABLE CELL CLONES HARBORING REPLICATING SARS-COV-2 RNA THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN (US) 2025-08-07 — — US disclosed
CN-118090962-A Synchronous quantitative detection method for ginkgo flavonoid components 浙江康恩贝制药股份有限公司 2024-05-28 — — CN disclosed
CN-115721633-B Application of hydroxy alizarin as T3SS small molecule inhibitor 山东大学 2024-05-03 — — CN disclosed
CN-115612114-B Copolymer membrane and method for enzymatic self-assembly synthesis and application thereof 中国科学院天津工业生物技术研究所 2024-02-20 — — CN disclosed
CN-115177694-B Plant composite extract and preparation method and application thereof 华中科技大学鄂州工业技术研究院 2024-02-13 — — CN disclosed
CN-115612403-B Self-assembled strong-adhesion copolymer film, coating method and application 中国科学院天津工业生物技术研究所 2023-12-01 — — CN disclosed
CN-117044519-A Method for improving flavonoid and cyanidin content in square bamboo body 南京林业大学 2023-11-14 — — CN disclosed
CN-114652836-B T3SS small molecule inhibitor and screening method and application thereof 山东大学 2023-06-20 — — CN disclosed
CN-114652836-A T3SS small-molecule inhibitor and screening method and application thereof 山东大学 2022-06-24 — — CN disclosed
CN-106309586-A Fugui Gutong granule and preparation method thereof 上海颂露医药科技有限公司 2017-01-11 — — CN disclosed
CN-106236846-A ZHENQI FUZHENG KELI and preparation method thereof 上海颂露医药科技有限公司 2016-12-21 — — CN disclosed
CN-106237236-A Tablet for promoting coronary circulation and preparation method thereof 上海颂露医药科技有限公司 2016-12-21 — — CN disclosed
CN-106177781-A XIAOSHUAN ZAIZAO WAN and preparation method thereof 上海颂露医药科技有限公司 2016-12-07 — — CN disclosed
CN-106109571-A GUANXIN DANSHEN JIAONANG and preparation method thereof 上海颂露医药科技有限公司 2016-11-16 — — CN disclosed
CN-104569170-A Method for detecting ginkgo leaf extract and diphyridamole injection preparation GUIZHOU YIBAI PHARMACEUTICAL 2015-04-29 — — CN disclosed
US-6555523-B1 Such as 3',4'-diacetoxy-5,6,7-trimethoxyflavone or naringin in the treatment HIV, picornavirus, and/or respiratory virus CASCADE ESTATES LTD. (MU) 2003-04-29 — — US disclosed
EP-1223928-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS Prendergast, Patrick Thomas (IE) 2002-07-24 — — EP disclosed
WO-2001003681-A2 USE OF FLAVONES, COUMARINS AND RELATED COMPOUNDS TO TREAT INFECTIONS PRENDERGAST PATRICK T (IE) 2001-01-18 — — WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250339399-A1 SUPRAMOLECULAR SELF-ASSEMBLY SYSTEM S100A8, TP53, AQP1 P4HB 1151/4885SYNJ2 2452/4885KDM4E 4766/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback